-   directed: true
    graph:
        _id: DB01158_MESH_D014693_1
        disease: Ventricular Fibrillation
        disease_mesh: MESH:D014693
        drug: bretylium
        drug_mesh: MESH:C045166
        drugbank: DB:DB01158
    links:
    -   key: decreases activity of
        source: MESH:C045166
        target: UniProt:P05023
    -   key: positively regulates
        source: UniProt:P05023
        target: GO:0061533
    -   key: positively correlated with
        source: GO:0061533
        target: GO:0042310
    -   key: positively correlated with
        source: GO:0042310
        target: HP:0011675
    -   key: manifestation of
        source: HP:0011675
        target: MESH:D014693
    multigraph: true
    nodes:
    -   id: MESH:C045166
        label: Drug
        name: bretylium
    -   id: UniProt:P05023
        label: Protein
        name: Sodium/potassium-transporting ATPase subunit alpha-1
    -   id: GO:0061533
        label: BiologicalProcess
        name: norepinephrine secretion, neurotransmission
    -   id: GO:0042310
        label: BiologicalProcess
        name: vasoconstriction
    -   id: HP:0011675
        label: PhenotypicFeature
        name: Arrhythmia
    -   id: MESH:D014693
        label: Disease
        name: Ventricular Fibrillation
    reference: 
    -   https://go.drugbank.com/drugs/DB01158#mechanism-of-action
    -   https://www.uniprot.org/uniprot/P05023#function
    -   https://en.wikipedia.org/wiki/Ventricular_fibrillation
-   directed: true
    graph:
        _id: DB11348_MESH_D006996_1
        disease: Hypocalcemia
        disease_mesh: MESH:D006996
        drug: calcium phosphate
        drug_mesh: MESH:C020243
        drugbank: DB:DB11348
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D002118
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: negatively regulates
        source: InterPro:IPR000276
        target: GO:0035898
    -   key: negatively correlated with
        source: GO:0035898
        target: GO:0070977
    -   key: positively correlated with
        source: GO:0070977
        target: GO:0055074
    -   key: negatively correlated with
        source: GO:0035898
        target: MESH:D002112
    -   key: positively regulates
        source: MESH:D002112
        target: UniProt:P20020
    -   key: positively regulates
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: positively regulates
        source: UniProt:P20020
        target: GO:0055074
    -   key: positively regulates
        source: UniProt:Q9H1D0
        target: GO:0055074
    -   key: negatively correlated with
        source: GO:0055074
        target: MESH:D006996
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: calcium phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphates
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcifediol
    -   id: GO:0055074
        label: BiologicalProcess
        name: calcium ion homeostasis
    -   id: GO:0035898
        label: BiologicalProcess
        name: parathyroid hormone secretion
    -   id: GO:0070977
        label: BiologicalProcess
        name: bone maturation
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor, rhodopsin-like
    -   id: UniProt:P20020
        label: Protein
        name: Plasma membrane calcium-transporting ATPase 1
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6
    -   id: MESH:D006996
        label: Disease
        name: Hypocalcemia
    reference: 
    -   https://go.drugbank.com/drugs/DB11348#mechanism-of-action
    -   https://www.uniprot.org/uniprot/P20020#function
    -   https://www.uniprot.org/uniprot/Q9H1D0#function
    -   https://en.wikipedia.org/wiki/Hypocalcemia
-   directed: true
    graph:
        _id: DB11348_MESH_D010024_1
        disease: Osteoporosis
        disease_mesh: MESH:D010024
        drug: calcium phosphate
        drug_mesh: MESH:C020243
        drugbank: DB:DB11348
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D002118
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: negatively regulates
        source: InterPro:IPR000276
        target: GO:0035898
    -   key: negatively correlated with
        source: GO:0035898
        target: GO:0070977
    -   key: positively correlated with
        source: GO:0070977
        target: GO:0055074
    -   key: negatively correlated with
        source: GO:0035898
        target: MESH:D002112
    -   key: positively regulates
        source: MESH:D002112
        target: UniProt:P20020
    -   key: positively regulates
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: positively regulates
        source: UniProt:P20020
        target: GO:0055074
    -   key: positively regulates
        source: UniProt:Q9H1D0
        target: GO:0055074
    -   key: negatively correlated with
        source: GO:0055074
        target: MESH:D010024
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: calcium phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphates
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcifediol
    -   id: GO:0055074
        label: BiologicalProcess
        name: calcium ion homeostasis
    -   id: GO:0035898
        label: BiologicalProcess
        name: parathyroid hormone secretion
    -   id: GO:0070977
        label: BiologicalProcess
        name: bone maturation
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor, rhodopsin-like
    -   id: UniProt:P20020
        label: Protein
        name: Plasma membrane calcium-transporting ATPase 1
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6
    -   id: MESH:D010024
        label: Disease
        name: Osteoporosis
    reference: 
    -   https://go.drugbank.com/drugs/DB11348#mechanism-of-action
    -   https://www.uniprot.org/uniprot/P20020#function
    -   https://www.uniprot.org/uniprot/Q9H1D0#function
    -   https://en.wikipedia.org/wiki/Osteoporosis
-   directed: true
    graph:
        _id: DB11348_MESH_D015663_1
        disease: Osteoporosis, Postmenopausal
        disease_mesh: MESH:D015663
        drug: calcium phosphate
        drug_mesh: MESH:C020243
        drugbank: DB:DB11348
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D002118
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: negatively regulates
        source: InterPro:IPR000276
        target: GO:0035898
    -   key: negatively correlated with
        source: GO:0035898
        target: GO:0070977
    -   key: positively correlated with
        source: GO:0070977
        target: GO:0055074
    -   key: negatively correlated with
        source: GO:0035898
        target: MESH:D002112
    -   key: positively regulates
        source: MESH:D002112
        target: UniProt:P20020
    -   key: positively regulates
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: positively regulates
        source: UniProt:P20020
        target: GO:0055074
    -   key: positively regulates
        source: UniProt:Q9H1D0
        target: GO:0055074
    -   key: negatively correlated with
        source: GO:0055074
        target: HP:0000939
    -   key: contributes to
        source: HP:0000939
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: calcium phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphates
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcifediol
    -   id: GO:0055074
        label: BiologicalProcess
        name: calcium ion homeostasis
    -   id: GO:0035898
        label: BiologicalProcess
        name: parathyroid hormone secretion
    -   id: GO:0070977
        label: BiologicalProcess
        name: bone maturation
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor, rhodopsin-like
    -   id: UniProt:P20020
        label: Protein
        name: Plasma membrane calcium-transporting ATPase 1
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6
    -   id: HP:0000939
        label: PhenotypicFeature
        name: Osteoporosis
    -   id: MESH:D015663
        label: Disease
        name: Osteoporosis, Postmenopausal
    reference: 
    -   https://go.drugbank.com/drugs/DB11348#mechanism-of-action
    -   https://www.uniprot.org/uniprot/P20020#function
    -   https://www.uniprot.org/uniprot/Q9H1D0#function
    -   https://en.wikipedia.org/wiki/Osteoporosis
-   comment: Fosphenytoin is a prodrug of phenytoin used for the treatment of epileptic seizures.
    directed: true
    graph:
        _id: DB01320_MESH_D004827_1
        disease: Epilepsy
        disease_mesh: MESH:D004827
        drug: fosphenytoin
        drug_mesh: MESH:C043114
        drugbank: DB:DB01320
    links:
    -   key: has metabolite
        source: MESH:C043114
        target: MESH:D010672
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D004827
    multigraph: true
    nodes:
    -   id: MESH:C043114
        label: Drug
        name: fosphenytoin
    -   id: MESH:D010672
        label: ChemicalSubstance
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004827
        label: Disease
        name: Epilepsy
    reference:
    -   https://go.drugbank.com/drugs/DB01320#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Epilepsy
-   comment: Fosphenytoin is a prodrug of phenytoin used for the treatment of epileptic seizures.
    directed: true
    graph:
        _id: DB01320_MESH_D013226_1
        disease: Status Epilepticus
        disease_mesh: MESH:D013226
        drug: fosphenytoin
        drug_mesh: MESH:C043114
        drugbank: DB:DB01320
    links:
    -   key: has metabolite
        source: MESH:C043114
        target: MESH:D010672
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: positively correlated with
        source: HP:0001250
        target: MESH:D013226
    multigraph: true
    nodes:
    -   id: MESH:C043114
        label: Drug
        name: fosphenytoin
    -   id: MESH:D010672
        label: ChemicalSubstance
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D013226
        label: Disease
        name: Status Epilepticus
    reference:
    -   https://go.drugbank.com/drugs/DB01320#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Status_epilepticus
-   directed: true
    graph:
        _id: DB00996_MESH_D051474_1
        disease: Neuralgia, Postherpetic
        disease_mesh: MESH:D051474
        drug: Gabapentin
        drug_mesh: MESH:D000077206
        drugbank: DB:DB00996
    links:
    -   key: decreases activity of
        source: MESH:D000077206
        target: UniProt:P54289
    -   key: participates in
        source: UniProt:P54289
        target: GO:0005245
    -   key: increases abundance of
        source: GO:0005245
        target: MESH:D013373
    -   key: positively correlated with
        source: MESH:D013373
        target: GO:0019233
    -   key: positively correlated with
        source: GO:0019233
        target: HP:0012534
    -   key: positively correlated with
        source: HP:0012534
        target: MESH:D051474
    multigraph: true
    nodes:
    -   id: MESH:D000077206
        label: Drug
        name: Gabapentin
    -   id: UniProt:P54289
        label: Protein
        name: Voltage-dependent calcium channel subunit alpha-2/delta-1
    -   id: GO:0005245
        label: MolecularActivity
        name: voltage-gated calcium channel activity
    -   id: MESH:D013373
        label: ChemicalSubstance
        name: Substance P
    -   id: GO:0019233
        label: BiologicalProcess
        name: sensory perception of pain
    -   id: HP:0012534
        label: PhenotypicFeature
        name: Dysesthesia
    -   id: MESH:D051474
        label: Disease
        name: Neuralgia, Postherpetic
    reference: 
    -   https://go.drugbank.com/drugs/DB00996#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Gabapentin#Pharmacology
    -   https://www.uniprot.org/uniprot/P54289#function
    -   https://en.wikipedia.org/wiki/Postherpetic_neuralgia
-   directed: true
    graph:
        _id: DB00996_MESH_D012148_1
        disease: Restless Legs Syndrome
        disease_mesh: MESH:D012148
        drug: Gabapentin
        drug_mesh: MESH:D000077206
        drugbank: DB:DB00996
    links:
    -   key: decreases activity of
        source: MESH:D000077206
        target: UniProt:P54289
    -   key: positively regulates
        source: UniProt:P54289
        target: GO:0006936
    -   key: positively correlated with
        source: GO:0006936
        target: HP:0012531
    -   key: positively correlated with
        source: HP:0012531
        target: MESH:D012148
    multigraph: true
    nodes:
    -   id: MESH:D000077206
        label: Drug
        name: Gabapentin
    -   id: UniProt:P54289
        label: Protein
        name: Voltage-dependent calcium channel subunit alpha-2/delta-1
    -   id: GO:0006936
        label: BiologicalProcess
        name: muscle contraction
    -   id: HP:0012531
        label: PhenotypicFeature
        name: Pain
    -   id: MESH:D012148
        label: Disease
        name: Restless Legs Syndrome
    reference: 
    -   https://go.drugbank.com/drugs/DB00996#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Gabapentin#Pharmacology
    -   https://www.uniprot.org/uniprot/P54289#function
    -   https://en.wikipedia.org/wiki/Restless_legs_syndrome
-   directed: true
    graph:
        _id: DB00996_MESH_D012148_2
        disease: Restless Legs Syndrome
        disease_mesh: MESH:D012148
        drug: Gabapentin
        drug_mesh: MESH:D000077206
        drugbank: DB:DB00996
    links:
    -   key: decreases activity of
        source: MESH:D000077206
        target: UniProt:P54289
    -   key: participates in
        source: UniProt:P54289
        target: GO:0005245
    -   key: increases abundance of
        source: GO:0005245
        target: MESH:D013373
    -   key: positively correlated with
        source: MESH:D013373
        target: GO:0019233
    -   key: positively correlated with
        source: GO:0019233
        target: HP:0012531
    -   key: positively correlated with
        source: HP:0012531
        target: MESH:D012148
    multigraph: true
    nodes:
    -   id: MESH:D000077206
        label: Drug
        name: Gabapentin
    -   id: UniProt:P54289
        label: Protein
        name: Voltage-dependent calcium channel subunit alpha-2/delta-1
    -   id: GO:0005245
        label: MolecularActivity
        name: voltage-gated calcium channel activity
    -   id: MESH:D013373
        label: ChemicalSubstance
        name: Substance P
    -   id: GO:0019233
        label: BiologicalProcess
        name: sensory perception of pain
    -   id: HP:0012531
        label: PhenotypicFeature
        name: Pain
    -   id: MESH:D012148
        label: Disease
        name: Restless Legs Syndrome
    reference: 
    -   https://go.drugbank.com/drugs/DB00996#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Gabapentin#Pharmacology
    -   https://www.uniprot.org/uniprot/P54289#function
    -   https://en.wikipedia.org/wiki/Restless_legs_syndrome
-   comment: Iproniazid is withdrawn in USA due to interactions with tyrosine in food products.
    directed: true
    graph:
        _id: DB04818_MESH_D003866_1
        disease: Depressive Disorder
        disease_mesh: MESH:D003866
        drug: Iproniazid
        drug_mesh: MESH:D007490
        drugbank: DB:DB04818
    links:
    -   key: decreases activity of
        source: MESH:D007490
        target: UniProt:P21397
    -   key: decreases activity of
        source: MESH:D007490
        target: UniProt:P27338
    -   key: has metabolite
        source: MESH:D007490
        target: MESH:C044821
    -   key: decreases activity of
        source: MESH:C044821
        target: UniProt:P21397
    -   key: decreases activity of
        source: MESH:C044821
        target: UniProt:P27338
    -   key: positively regulates
        source: UniProt:P21397
        target: GO:0042429
    -   key: positively regulates
        source: UniProt:P21397
        target: GO:0042420
    -   key: positively regulates
        source: UniProt:P27338
        target: GO:0042420
    -   key: decreases abundance of
        source: GO:0042429
        target: MESH:D012701
    -   key: decreases abundance of
        source: GO:0042420
        target: MESH:D004298
    -   key: negatively correlated with
        source: MESH:D012701
        target: HP:0000716
    -   key: negatively correlated with
        source: MESH:D004298
        target: HP:0000716
    -   key: manifestation of
        source: HP:0000716
        target: MESH:D003866
    multigraph: true
    nodes:
    -   id: MESH:D007490
        label: Drug
        name: Iproniazid
    -   id: UniProt:P21397
        label: Protein
        name: Amine oxidase [flavin-containing] A
    -   id: UniProt:P27338
        label: Protein
        name: Amine oxidase [flavin-containing] B
    -   id: MESH:C044821
        label: ChemicalSubstance
        name: 1-isopropylhydrazine
    -   id: GO:0042429
        label: BiologicalProcess
        name: serotonin catabolic process
    -   id: GO:0042420
        label: BiologicalProcess
        name: dopamine catabolic process
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: MESH:D004298
        label: ChemicalSubstance
        name: Dopamine
    -   id: HP:0000716
        label: PhenotypicFeature
        name: Depression
    -   id: MESH:D003866
        label: Disease
        name: Depressive Disorder
    reference: 
    -   https://go.drugbank.com/drugs/DB04818#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Iproniazid#Reactions_and_mechanism_of_action
    -   https://en.wikipedia.org/wiki/Monoamine_oxidase_inhibitor#Mechanism_of_action
    -   https://www.uniprot.org/uniprot/P21397#function
    -   https://www.uniprot.org/uniprot/P27338#function
    -   https://en.wikipedia.org/wiki/Depression_(mood)
    -   https://en.wikipedia.org/wiki/Major_depressive_disorder
-   directed: true
    graph:
        _id: DB01421_MESH_D006501_1
        disease: Hepatic Encephalopathy
        disease_mesh: MESH:D006501
        drug: Paromomycin
        drug_mesh: MESH:D010303
        drugbank: DB:DB01421
    links:
    -   key: negatively regulates
        source: MESH:D010303
        target: MESH:D012336
    -   key: part of
        source: MESH:D012336
        target: GO:0044391
    -   key: positively regulates
        source: GO:0044391
        target: GO:0006412
    -   key: in taxon
        source: GO:0006412
        target: NCBITaxon:2
    -   key: causes
        source: NCBITaxon:2
        target: MESH:D006501
    multigraph: true
    nodes:
    -   id: MESH:D010303
        label: Drug
        name: Paromomycin
    -   id: MESH:D012336
        label: ChemicalSubstance
        name: RNA, Ribosomal, 16S
    -   id: GO:0044391
        label: CellularComponent
        name: ribosomal subunit
    -   id: GO:0006412
        label: BiologicalProcess
        name: translation
    -   id: NCBITaxon:2
        label: OrganismTaxon
        name: Bacteria
    -   id: MESH:D006501
        label: Disease
        name: Hepatic Encephalopathy
    reference: 
    -   https://go.drugbank.com/drugs/DB01421#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Hepatic_encephalopathy
-   comment: Perindopril is a nonsulfhydryl prodrug of perindoprilat, which is used to treat hypertension.
    directed: true
    graph:
        _id: DB00790_MESH_D006973_1
        disease: Hypertension
        disease_mesh: MESH:D006973
        drug: Perindopril
        drug_mesh: MESH:D020913
        drugbank: DB:DB00790
    links:
    -   key: has metabolite
        source: MESH:D020913
        target: MESH:C053500
    -   key: decreases activity of
        source: MESH:C053500
        target: UniProt:P12821
    -   key: positively regulates
        source: UniProt:P12821
        target: REACT:R-HSA-2022377
    -   key: positively regulates
        source: REACT:R-HSA-2022377
        target: GO:0042310
    -   key: contributes to
        source: GO:0042310
        target: HP:0032263
    -   key: positively correlated with
        source: HP:0032263
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:D020913
        label: Drug
        name: Perindopril
    -   id: MESH:C053500
        label: ChemicalSubstance
        name: perindoprilat
    -   id: UniProt:P12821
        label: Protein
        name: Angiotensin-converting enzyme
    -   id: REACT:R-HSA-2022377
        label: Pathway
        name: Metabolism of Angiotensinogen to Angiotensins
    -   id: GO:0042310
        label: BiologicalProcess
        name: vasoconstriction
    -   id: HP:0032263
        label: PhenotypicFeature
        name: Increased blood pressure
    -   id: MESH:D006973
        label: Disease
        name: Hypertension
    reference:
    -   https://go.drugbank.com/drugs/DB00790#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Perindopril
    -   https://www.uniprot.org/uniprot/P12821#function
    -   https://en.wikipedia.org/wiki/Hypertension
-   directed: true
    graph:
        _id: DB00252_MESH_D004828_1
        disease: Epilepsies, Partial
        disease_mesh: MESH:D004828
        drug: Phenytoin
        drug_mesh: MESH:D010672
        drugbank: DB:DB00252
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: positively correlated with
        source: HP:0001250
        target: MESH:D004828
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004828
        label: Disease
        name: Epilepsies, Partial
    reference:
    -   https://go.drugbank.com/drugs/DB00252#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Focal_seizure
-   directed: true
    graph:
        _id: DB00252_MESH_D004827_1
        disease: Epilepsy
        disease_mesh: MESH:D004827
        drug: Phenytoin
        drug_mesh: MESH:D010672
        drugbank: DB:DB00252
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D004827
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004827
        label: Disease
        name: Epilepsy
    reference:
    -   https://go.drugbank.com/drugs/DB00252#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Epilepsy
-   directed: true
    graph:
        _id: DB00252_MESH_D004830_1
        disease: Epilepsy, Tonic-Clonic
        disease_mesh: MESH:D004830
        drug: Phenytoin
        drug_mesh: MESH:D010672
        drugbank: DB:DB00252
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: positively correlated with
        source: HP:0001250
        target: MESH:D004830
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004830
        label: Disease
        name: Epilepsy, Tonic-Clonic
    reference:
    -   https://go.drugbank.com/drugs/DB00252#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Generalized_tonic%E2%80%93clonic_seizure
-   directed: true
    graph:
        _id: DB00252_MESH_D065768_1
        disease: Lennox Gastaut Syndrome
        disease_mesh: MESH:D065768
        drug: Phenytoin
        drug_mesh: MESH:D010672
        drugbank: DB:DB00252
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D065768
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D065768
        label: Disease
        name: Lennox Gastaut Syndrome
    reference:
    -   https://go.drugbank.com/drugs/DB00252#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Lennox%E2%80%93Gastaut_syndrome
-   directed: true
    graph:
        _id: DB00252_MESH_D012640_1
        disease: Seizures
        disease_mesh: MESH:D012640
        drug: Phenytoin
        drug_mesh: MESH:D010672
        drugbank: DB:DB00252
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: MESH:D012640
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: MESH:D012640
        label: Disease
        name: Seizures
    reference:
    -   https://go.drugbank.com/drugs/DB00252#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Seizure
-   directed: true
    graph:
        _id: DB00252_MESH_D013226_1
        disease: Status Epilepticus
        disease_mesh: MESH:D013226
        drug: Phenytoin
        drug_mesh: MESH:D010672
        drugbank: DB:DB00252
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: InterPro:IPR001696
    -   key: positively regulates
        source: InterPro:IPR001696
        target: GO:0098870
    -   key: contributes to
        source: GO:0098870
        target: HP:0001250
    -   key: positively correlated with
        source: HP:0001250
        target: MESH:D013226
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: InterPro:IPR001696
        label: GeneFamily
        name: Voltage gated sodium channel, alpha subunit
    -   id: GO:0098870
        label: BiologicalProcess
        name: action potential propagation
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D013226
        label: Disease
        name: Status Epilepticus
    reference:
    -   https://go.drugbank.com/drugs/DB00252#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Phenytoin#Mechanism_of_action
    -   https://en.wikipedia.org/wiki/Status_epilepticus
-   comment: Pipotiazine is under investigational in USA but approved in UK and other countries for schizophrenia.
    directed: true
    graph:
        _id: DB01621_MESH_D012559_1
        disease: Schizophrenia
        disease_mesh: MESH:D012559
        drug: Pipotiazine
        drug_mesh: MESH:null
        drugbank: DB:DB01621
    links:
    -   key: decreases activity of
        source: DB:DB01621
        target: InterPro:IPR000929
    -   key: correlated with
        source: InterPro:IPR000929
        target: MESH:D004298
    -   key: positively correlated with
        source: MESH:D004298
        target: HP:0000738
    -   key: manifestation of
        source: HP:0000738
        target: MESH:D012559
    multigraph: true
    nodes:
    -   id: DB:DB01621
        label: Drug
        name: Pipotiazine
    -   id: InterPro:IPR000929
        label: GeneFamily
        name: Dopamine receptor family
    -   id: MESH:D004298
        label: ChemicalSubstance
        name: Dopamine
    -   id: HP:0000738
        label: PhenotypicFeature
        name: Hallucinations 
    -   id: MESH:D012559
        label: Disease
        name: Schizophrenia
    reference: 
    -   https://go.drugbank.com/drugs/DB01621#mechanism-of-action
    -   https://drugs.ncats.io/substances?q=%22PIPOTIAZINE%22
    -   https://en.wikipedia.org/wiki/Schizophrenia
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D001161_1
        disease: Arteriosclerosis
        disease_mesh: MESH:D001161
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: decreases activity of
        source: CHEBI:169041
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: located in
        source: MESH:D002784
        target: UBERON:0001637
    -   key: location of
        source: UBERON:0001637
        target: MESH:D001161
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UBERON:0001637
        label: GrossAnatomicalStructure
        name: artery
    -   id: MESH:D001161
        label: Disease
        name: Arteriosclerosis
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://www.mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/symptoms-causes/syc-20350569
    -   https://en.wikipedia.org/wiki/Arteriosclerosis
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D006937_1
        disease: Hypercholesterolemia
        disease_mesh: MESH:D006937
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: decreases activity of
        source: CHEBI:169041
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006937
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: MESH:D006937
        label: Disease
        name: Hypercholesterolemia
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://en.wikipedia.org/wiki/Hypercholesterolemia
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D006950_1
        disease: Hyperlipidemia, Familial Combined
        disease_mesh: MESH:D006950
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: decreases activity of
        source: CHEBI:169041
        target: UniProt:P04035
    -   key: negatively regulates
        source: CHEBI:169041
        target: REACT:R-HSA-8866423
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: positively regulates
        source: REACT:R-HSA-8866423
        target: GO:0019432
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: increases abundance of
        source: GO:0019432
        target: MESH:D014280
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006950
    -   key: positively correlated with
        source: MESH:D014280
        target: MESH:D006950
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: cholesterol biosynthetic process
    -   id: REACT:R-HSA-8866423
        label: Pathway
        name: VLDL assembly
    -   id: GO:0019432
        label: BiologicalProcess
        name: triglyceride biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglycerides
    -   id: MESH:D006950
        label: Disease
        name: Hyperlipidemia, Familial Combined
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://www.uniprot.org/uniprot/P04035#function
    -   https://en.wikipedia.org/wiki/Combined_hyperlipidemia
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D006952_1
        disease: Hyperlipoproteinemia Type III
        disease_mesh: MESH:D006952
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: decreases activity of
        source: CHEBI:169041
        target: UniProt:P04035
    -   key: negatively regulates
        source: CHEBI:169041
        target: REACT:R-HSA-8866423
    -   key: increases activity of
        source: CHEBI:169041
        target: UniProt:P02647
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: positively regulates
        source: REACT:R-HSA-8866423
        target: GO:0019432
    -   key: positively regulates
        source: UniProt:P02647
        target: GO:0034380
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: increases abundance of
        source: GO:0019432
        target: MESH:D014280
    -   key: increases abundance of
        source: GO:0034380
        target: MESH:D008076
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006952
    -   key: positively correlated with
        source: MESH:D014280
        target: MESH:D006952
    -   key: negatively correlated with
        source: MESH:D008076
        target: MESH:D006952
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: UniProt:P02647
        label: Protein
        name: Apolipoprotein A-I
    -   id: GO:0006695
        label: BiologicalProcess
        name: cholesterol biosynthetic process
    -   id: REACT:R-HSA-8866423
        label: Pathway
        name: VLDL assembly
    -   id: GO:0034380
        label: BiologicalProcess
        name: high-density lipoprotein particle assembly
    -   id: GO:0019432
        label: BiologicalProcess
        name: triglyceride biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglycerides
    -   id: MESH:D008076
        label: ChemicalSubstance
        name: Cholesterol, HDL
    -   id: MESH:D006952
        label: Disease
        name: Hyperlipoproteinemia Type III
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://www.uniprot.org/uniprot/P04035#function
    -   https://www.uniprot.org/uniprot/P02647#function
    -   https://en.wikipedia.org/wiki/Familial_dysbetalipoproteinemia
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D015228_1
        disease: Hypertriglyceridemia
        disease_mesh: MESH:D015228
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: negatively regulates
        source: CHEBI:169041
        target: REACT:R-HSA-8866423
    -   key: positively regulates
        source: REACT:R-HSA-8866423
        target: GO:0019432
    -   key: increases abundance of
        source: GO:0019432
        target: MESH:D014280
    -   key: positively correlated with
        source: MESH:D014280
        target: MESH:D015228
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: REACT:R-HSA-8866423
        label: Pathway
        name: VLDL assembly
    -   id: GO:0019432
        label: BiologicalProcess
        name: triglyceride biosynthetic process
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglycerides
    -   id: MESH:D015228
        label: Disease
        name: Hypertriglyceridemia
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://en.wikipedia.org/wiki/Hypertriglyceridemia
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D052456_1
        disease: Hypoalphalipoproteinemias
        disease_mesh: MESH:D052456
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: increases activity of
        source: CHEBI:169041
        target: UniProt:P02647
    -   key: positively regulates
        source: UniProt:P02647
        target: GO:0034380
    -   key: increases abundance of
        source: GO:0034380
        target: MESH:D008076
    -   key: negatively correlated with
        source: MESH:D008076
        target: MESH:D052456
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: UniProt:P02647
        label: Protein
        name: Apolipoprotein A-I
    -   id: GO:0034380
        label: BiologicalProcess
        name: high-density lipoprotein particle assembly
    -   id: MESH:D008076
        label: ChemicalSubstance
        name: Cholesterol, HDL
    -   id: MESH:D052456
        label: Disease
        name: Hypoalphalipoproteinemias
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://www.uniprot.org/uniprot/P02647#function
    -   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531/
    -   https://en.wikipedia.org/wiki/Hypoalphalipoproteinemia
-   comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.
    directed: true
    graph:
        _id: DB00641_MESH_D020521_1
        disease: Stroke
        disease_mesh: MESH:D020521
        drug: Simvastatin
        drug_mesh: MESH:D019821
        drugbank: DB:DB00641
    links:
    -   key: has metabolite
        source: MESH:D019821
        target: CHEBI:169041
    -   key: decreases activity of
        source: CHEBI:169041
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: HP:0002621
    -   key: positively correlated with
        source: HP:0002621
        target: MESH:D020521
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: CHEBI:169041
        label: ChemicalSubstance
        name: simvastatin hydroxy acid
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: HP:0002621
        label: PhenotypicFeature
        name: Atherosclerosis
    -   id: MESH:D020521
        label: Disease
        name: Stroke
    reference:
    -   https://go.drugbank.com/drugs/DB00641#mechanism-of-action
    -   https://en.wikipedia.org/wiki/Simvastatin#Pharmacology
    -   https://en.wikipedia.org/wiki/Stroke
-   comment: The drug, tofogliflozin is under investigational.
    directed: true
    graph:
        _id: DB11824_MESH_D003924_1
        disease: Diabetes Mellitus, Type 2
        disease_mesh: MESH:D003924
        drug: Tofogliflozin
        drug_mesh: MESH:C575086
        drugbank: DB:DB11824
    links:
    -   key: decreases activity of
        source: DB:DB11824
        target: UniProt:P31639
    -   key: positively regulates
        source: UniProt:P31639
        target: GO:0035623
    -   key: correlated with
        source: GO:0035623
        target: MESH:D001786
    -   key: positively correlated with
        source: MESH:D001786
        target: MESH:D003924
    multigraph: true
    nodes:
    -   id: DB:DB11824
        label: Drug
        name: Tofogliflozin
    -   id: UniProt:P31639
        label: Protein
        name: Sodium/glucose cotransporter 2
    -   id: GO:0035623
        label: BiologicalProcess
        name: renal glucose absorption
    -   id: MESH:D001786
        label: ChemicalSubstance
        name: Blood Glucose
    -   id: MESH:D003924
        label: Disease
        name: Diabetes Mellitus, Type 2
    reference: 
    -   https://go.drugbank.com/drugs/DB11824#mechanism-of-action
    -   https://drugs.ncats.io/substances?q=%22TOFOGLIFLOZIN%22
    -   https://en.wikipedia.org/wiki/Tofogliflozin
    -   https://www.uniprot.org/uniprot/P31639#function
    -   https://en.wikipedia.org/wiki/Type_2_diabetes
